Back to results
WithdrawnPhase 2

GV1001 Subcutaneous(SC) for the Treatment of Moderate Alzheimer's Disease (AD)

NCT03959553

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

GV1001 Subcutaneous(SC) for the Treatment of Moderate Alzheimer's Disease (AD) — TrialFind